59 related articles for article (PubMed ID: 9523233)
1. Monoclonal antibodies define a cellular antigen involved in HTLV-I infection.
Agadjanyan MG; Chattergoon MA; Petrushina I; Bennett M; Kim J; Ugen KE; Kieber-Emmons T; Weiner DB
Hybridoma; 1998 Feb; 17(1):9-19. PubMed ID: 9523233
[TBL] [Abstract][Full Text] [Related]
2. Identification of an 80-kilodalton membrane glycoprotein important for human T-cell leukemia virus type I and type II syncytium formation and infection.
Agadjanyan MG; Ugen KE; Wang B; Williams WV; Weiner DB
J Virol; 1994 Jan; 68(1):485-93. PubMed ID: 8254759
[TBL] [Abstract][Full Text] [Related]
3. Identification of membrane antigen C33 recognized by monoclonal antibodies inhibitory to human T-cell leukemia virus type 1 (HTLV-1)-induced syncytium formation: altered glycosylation of C33 antigen in HTLV-1-positive T cells.
Fukudome K; Furuse M; Imai T; Nishimura M; Takagi S; Hinuma Y; Yoshie O
J Virol; 1992 Mar; 66(3):1394-401. PubMed ID: 1738199
[TBL] [Abstract][Full Text] [Related]
4. Syncytium-inhibiting monoclonal antibodies produced against human T-cell lymphotropic virus type 1-infected cells recognize class II major histocompatibility complex molecules and block by protein crowding.
Hildreth JE
J Virol; 1998 Dec; 72(12):9544-52. PubMed ID: 9811687
[TBL] [Abstract][Full Text] [Related]
5. Molecular cloning, expression, and biological characterization of an HTLV-II envelope glycoprotein: HIV-1 expression is permissive for HTLV-II-induced cell fusion.
Wang B; Agadjanyan MG; Srikantan V; Ugen KE; Hall W; Kaplan MH; Dang K; Williams WV; Weiner DB
AIDS Res Hum Retroviruses; 1993 Sep; 9(9):849-60. PubMed ID: 8257634
[TBL] [Abstract][Full Text] [Related]
6. A glycoprotein antigen detected with new monoclonal antibodies on the surface of human lymphocytes infected with human T-cell leukemia virus type-I (HTLV-I).
Tanaka Y; Inoi T; Tozawa H; Yamamoto N; Hinuma Y
Int J Cancer; 1985 Nov; 36(5):549-55. PubMed ID: 2997042
[TBL] [Abstract][Full Text] [Related]
7. Induction of strong homotypic adhesion in human T cell lines positive with human T-cell leukemia virus type 1 by monoclonal antibodies to MHC class I and beta 2-microglobulin.
Furuse M; Fukudome K; Imai T; Uwabe K; Hinuma Y; Yoshie O
Cell Immunol; 1992 Sep; 143(2):298-309. PubMed ID: 1380895
[TBL] [Abstract][Full Text] [Related]
8. [Localization of HTLV-I-associated antigens in adult T cell leukemia cells and HTLV-I-infected cell line cells].
Jin FX; Iwatsuki K; Horiguchi D; Sugaya K; Nakayama F; Koide M; Takigawa M; Yamada M
Nihon Hifuka Gakkai Zasshi; 1991 Feb; 101(2):89-95. PubMed ID: 2072580
[TBL] [Abstract][Full Text] [Related]
9. Antibodies to the envelope glycoprotein of human T cell leukemia virus type 1 robustly activate cell-mediated cytotoxic responses and directly neutralize viral infectivity at multiple steps of the entry process.
Kuo CW; Mirsaliotis A; Brighty DW
J Immunol; 2011 Jul; 187(1):361-71. PubMed ID: 21646298
[TBL] [Abstract][Full Text] [Related]
10. Identification of new epitopes recognized by human monoclonal antibodies with neutralizing and antibody-dependent cellular cytotoxicity activities specific for human T cell leukemia virus type 1.
Kuroki M; Nakamura M; Itoyama Y; Tanaka Y; Shiraki H; Baba E; Esaki T; Tatsumoto T; Nagafuchi S; Nakano S
J Immunol; 1992 Aug; 149(3):940-8. PubMed ID: 1378869
[TBL] [Abstract][Full Text] [Related]
11. Identification of several cell surface proteins of non-T, non-B acute lymphoblastic leukemia by using monoclonal antibodies.
Quackenbush EJ; Letarte M
J Immunol; 1985 Feb; 134(2):1276-85. PubMed ID: 3155538
[TBL] [Abstract][Full Text] [Related]
12. Development of a monoclonal antibody-based p24 capsid antigen detection assay for HTLV-I, HTLV-II, and STLV-I infection.
Toedter G; Pearlman S; Hofheinz D; Blakeslee J; Cockerell G; Dezzutti C; Yee J; Lal RB; Lairmore M
AIDS Res Hum Retroviruses; 1992 Apr; 8(4):527-32. PubMed ID: 1318063
[TBL] [Abstract][Full Text] [Related]
13. Characterization of monoclonal antibodies directed against the gp46 of human T-cell leukemia virus type I.
Edouard E; Legrand E; Astier-Gin T; Dalibart R; Geoffre S; Dalbon P; Guillemain B; Londos-Gagliardi D
Leukemia; 1994 Apr; 8 Suppl 1():S60-4. PubMed ID: 7512182
[TBL] [Abstract][Full Text] [Related]
14. Identification of membrane antigens important for adsorption of human T-cell leukaemia virus type I.
Fu DX; Haraguchi Y; Jinno A; Yang D; Hoshino H
Res Virol; 1998; 149(6):383-92. PubMed ID: 9923014
[TBL] [Abstract][Full Text] [Related]
15. IgM secreted by human T lymphoma virus-I-infected and transformed human B cell clones recognize a 66-kilodalton host-encoded protein.
Ng VL; Rainer C; Oliver MR; Marsh J; Wood P; Reyes GR; McGrath MS
J Immunol; 1989 Oct; 143(8):2501-7. PubMed ID: 2477445
[TBL] [Abstract][Full Text] [Related]
16. An antigenic structure of the trans-activator protein encoded by human T-cell leukemia virus type-I (HTLV-I), as defined by a panel of monoclonal antibodies.
Tanaka Y; Masuda M; Yoshida A; Shida H; Nyunoya H; Shimotohno K; Tozawa H
AIDS Res Hum Retroviruses; 1992 Feb; 8(2):227-35. PubMed ID: 1371693
[TBL] [Abstract][Full Text] [Related]
17. Mapping of immunogenic regions of human T cell leukemia virus type I (HTLV-I) gp46 and gp21 envelope glycoproteins with env-encoded synthetic peptides and a monoclonal antibody to gp46.
Palker TJ; Tanner ME; Scearce RM; Streilein RD; Clark ME; Haynes BF
J Immunol; 1989 Feb; 142(3):971-8. PubMed ID: 2563272
[TBL] [Abstract][Full Text] [Related]
18. Heat shock cognate protein 70 is a cell fusion-enhancing factor but not an entry factor for human T-cell lymphotropic virus type I.
Fang D; Haraguchi Y; Jinno A; Soda Y; Shimizu N; Hoshino H
Biochem Biophys Res Commun; 1999 Aug; 261(2):357-63. PubMed ID: 10425190
[TBL] [Abstract][Full Text] [Related]
19. Role of the HTLV-III/LAV envelope in syncytium formation and cytopathicity.
Sodroski J; Goh WC; Rosen C; Campbell K; Haseltine WA
Nature; 1986 Jul 31-Aug 6; 322(6078):470-4. PubMed ID: 3016552
[TBL] [Abstract][Full Text] [Related]
20. Multiple neutralizing B-cell epitopes of human T-cell leukemia virus type 1 (HTLV-1) identified by human monoclonal antibodies. A basis for the design of an HTLV-1 peptide vaccine.
Baba E; Nakamura M; Tanaka Y; Kuroki M; Itoyama Y; Nakano S; Niho Y
J Immunol; 1993 Jul; 151(2):1013-24. PubMed ID: 7687611
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
